CLINICAL PRESENTATION AND TREATMENT OF PHARYNGEAL TONSIL HYPERTROPHY IN CHILDREN WITH TORCH INFECTION

Abstract

According to the data of the Tashkent Pediatric Medical Institute clinic, hypertrophy of the pharyngeal tonsils mainly develops in children aged 3 to 6 years 31 (51.6%) and from 7 to 10 years 17 (28.3%), while at the age of 11-16 years, there were 12 (20.1%) children. The main clinical symptoms indicating the presence of herpesvirus infection in OGM are regional cervical lymphadenitis (14.8%), as well as recurrent exudative otitis media (14.8%). The most effective treatment in children with GHM infected with herpesviruses is a combined method, including adenotomy with the prescription of antibacterial and antiviral drugs in the preoperative period (95%), while with surgical, conservative treatment, the effectiveness is lower (81.2 and 50%, respectively).